# A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis

> **NCT00139893** · NA · COMPLETED · sponsor: **UCB Pharma**

## Conditions studied

- Diabetic Gastroparesis

## Interventions

- **DRUG:** Reglan ODT

## Key facts

- **NCT ID:** NCT00139893
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2005-10
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139893, "A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00139893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*